PET Study Examining the Dopaminergic Activity of Armodafinil in Adults
NCT00592943
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
armodafinil
Sponsor
Massachusetts General Hospital